Kunnumakkara, Ajaikumar B <br/><br/>
Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.  [electronic resource] 

 -  International journal of cancer  Nov 2009 
 - 2187-97 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.24593  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Capecitabine<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Colorectal Neoplasms--drug therapy<br/>Curcumin--pharmacology<br/>Cyclin D1--genetics<br/>Cyclooxygenase 2--genetics<br/>Deoxycytidine--analogs & derivatives<br/>Drug Synergism<br/>Fluorouracil--analogs & derivatives<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Male<br/>Matrix Metalloproteinase 9--genetics<br/>Mice<br/>NF-kappa B--antagonists & inhibitors<br/>Neoplasm Metastasis--prevention & control<br/>Receptors, CXCR4<br/>Vascular Endothelial Growth Factor A--genetics